DroneShield's Trust Gap: Why a 74% Revenue Forecast Can't Lift a Share Price Down 70%

DroneShield's shares fall 37% YTD despite 74% revenue growth forecast, as regulatory probe and valuation recalibration weigh on the counter-drone specialist.

There is a peculiar disconnect at the heart of DroneShield's current market narrative. The Australian counter-drone specialist keeps signing contracts and projecting robust growth, yet its share price continues to bleed value. Investors who bought at the October peak of EUR 3.79 are now sitting on losses of roughly 70 percent, with the stock changing hands around EUR 1.14–1.18.

The latest development — the launch of RFRecon, a portable RF intelligence solution for defense and security customers — arrives at a delicate moment. Product announcements rarely move the needle for defense suppliers on their own, and this one landed as the company's credibility is being tested from multiple directions.

A Stock That Can't Catch a Bid

The technical picture offers little comfort to bulls. The shares trade 17 percent below their 50-day moving average and a steeper 37 percent below the 200-day average. The relative strength index sits at 38.7, indicating weak momentum without the oversold conditions that often precede a durable bottom.

Over the past 30 days, the stock has shed 15 percent, and the year-to-date decline stands at 37 percent. Friday's pre-market session added another 3.2 percent drop to EUR 1.14. The annualized volatility of 75 percent underscores just how violently this equity can swing in either direction.

One mitigating detail: the share price remains 39 percent above its November low of EUR 0.8230. That suggests the market has already attempted a recovery once — and abandoned it. The current weakness reads as a test of whether that November floor holds or whether the growth story is being permanently repriced.

The Operating Reality vs. the Chart

Here is where the story gets complicated. The business itself is not collapsing. DroneShield projects first-half 2026 revenue of USD 125.8 million, a 74 percent jump from the prior-year period. Management has guided to full-year 2026 revenue between USD 250 million and USD 270 million, implying 15 to 25 percent growth over 2025, underpinned by secured orders and anticipated bookings.

The contract pipeline remains active. Recent wins include European defense orders worth AUD 23.2 million for two vehicle-mounted counter-drone systems, routed through a Benelux distributor to a European military customer. Earlier, the company disclosed a USD 24.9 million agreement with the US Department of Defense's Joint Interagency Task Force 401, with an initial tranche of USD 19.3 million.

This is not a company with a drying order book. It is a stock whose valuation ran too far in 2025 and is now being recalibrated as growth cools from triple-digit rates to a level that is still strong but far more ordinary.

Two Clouds Over Any Rally

Even positive headlines are struggling to stabilize the share price, and two factors explain why.

First, there is the unresolved regulatory matter. Australia's corporate regulator ASIC disclosed an investigation on May 11, 2026, into company disclosures and share trading from November 2025 — a revelation that triggered a 16 percent single-day plunge at the time. Until that probe concludes, every attempted recovery remains conditional.

Second, skepticism from a major sell-side house has hardened. Jefferies analyst Will Richardson cut his price target to AUD 2.05 — a 27 percent reduction — while maintaining an underperform rating. He trimmed his 2026–2028 revenue forecasts by roughly 9 percent, citing a lack of material contract wins and a shrinking delivery pipeline. That assessment sits awkwardly alongside the contract announcements above, highlighting a genuine divide between optimists betting on structural tailwinds from rising defense budgets and pessimists pointing to decelerating order momentum.

What RFRecon Must Prove

The bull case hinges on whether RFRecon can move from announcement to revenue. The chain that matters — customer adoption, software integration, manufacturing scale-up, and firm order volumes — will determine whether the product becomes a growth driver or just another line item in a long list of press releases.

Optimists note that discounted cash flow analysis suggests a fair value well above current levels, implying the market is pricing in considerable skepticism. A successful RFRecon rollout would also diversify the company beyond its existing counter-drone business, reducing reliance on individual large projects. Geopolitical tailwinds — including US tariffs on drones and drone components that have drawn protests from China — could further elevate the strategic importance of Western defense suppliers.

The bear case is equally concrete. The stock's persistent decline, independent of product news, reflects entrenched investor distrust. The RSI shows no imminent technical reversal. And RFRecon remains a product launch, not a confirmed order pipeline. If implementation stumbles — extended customer trials, production delays — the market could read that as further evidence that DroneShield is falling short of the expectations set during its boom phase.

The Interim Report as the Real Catalyst

With the formal half-year report due shortly, the market capitalization of roughly EUR 1.06 billion already prices in substantial caution. Given the technical damage — a share price well below all key moving averages and extreme volatility — the stock is more likely to react to headlines than to grind higher on growth metrics alone.

The upcoming report will test whether operational reality can finally separate itself from the beaten-down share price. Until then, DroneShield remains a stock where the fundamentals speak for themselves, but the market prefers to wait for the ASIC investigation to conclude before restoring confidence. For RFRecon, the proof will come in the months ahead — when the market sees whether the promise translates into purchase orders.